Metropolitan Life Insurance Company (MetLife)’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,129
Closed -$11.1K 2485
2023
Q1
$11.1K Sell
1,129
-117
-9% -$1.15K ﹤0.01% 2120
2022
Q4
$23.3K Hold
1,246
﹤0.01% 1931
2022
Q3
$25.8K Buy
1,246
+585
+89% +$12.1K ﹤0.01% 1887
2022
Q2
$13.7K Sell
661
-458
-41% -$9.51K ﹤0.01% 2225
2022
Q1
$48.2K Sell
1,119
-2,827
-72% -$122K ﹤0.01% 1620
2021
Q4
$236K Sell
3,946
-13
-0.3% -$778 ﹤0.01% 1912
2021
Q3
$340K Sell
3,959
-559
-12% -$48K ﹤0.01% 1687
2021
Q2
$503K Buy
4,518
+346
+8% +$38.5K 0.01% 1518
2021
Q1
$465K Buy
4,172
+301
+8% +$33.5K 0.01% 1470
2020
Q4
$411K Buy
3,871
+97
+3% +$10.3K 0.01% 1487
2020
Q3
$525K Buy
3,774
+132
+4% +$18.4K 0.01% 1188
2020
Q2
$1.18M Buy
3,642
+1,145
+46% +$370K 0.02% 638
2020
Q1
$223K Sell
2,497
-272
-10% -$24.3K ﹤0.01% 1532
2019
Q4
$110K Buy
2,769
+2,143
+342% +$84.9K ﹤0.01% 2282
2019
Q3
$15.4K Sell
626
-1,815
-74% -$44.6K ﹤0.01% 2559
2019
Q2
$86.1K Hold
2,441
﹤0.01% 2384
2019
Q1
$109K Buy
2,441
+63
+3% +$2.82K ﹤0.01% 2276
2018
Q4
$114K Hold
2,378
﹤0.01% 2184
2018
Q3
$159K Hold
2,378
﹤0.01% 2166
2018
Q2
$112K Buy
2,378
+278
+13% +$13.1K ﹤0.01% 2257
2018
Q1
$119K Buy
2,100
+697
+50% +$39.4K ﹤0.01% 2202
2017
Q4
$70K Sell
1,403
-2,975
-68% -$148K ﹤0.01% 2435
2017
Q3
$333K Buy
4,378
+80
+2% +$6.09K ﹤0.01% 1966
2017
Q2
$404K Hold
4,298
﹤0.01% 1861
2017
Q1
$341K Buy
4,298
+335
+8% +$26.6K ﹤0.01% 1921
2016
Q4
$330K Sell
3,963
-351
-8% -$29.2K ﹤0.01% 2031
2016
Q3
$482K Sell
4,314
-99
-2% -$11.1K ﹤0.01% 1728
2016
Q2
$489K Hold
4,413
﹤0.01% 1723
2016
Q1
$461K Hold
4,413
﹤0.01% 1622
2015
Q4
$356K Hold
4,413
﹤0.01% 1859
2015
Q3
$306K Sell
4,413
-82
-2% -$5.69K ﹤0.01% 1966
2015
Q2
$440K Buy
+4,495
New +$440K ﹤0.01% 1834
2015
Q1
Sell
-3,910
Closed -$431K 2318
2014
Q4
$431K Buy
3,910
+404
+12% +$44.5K ﹤0.01% 1863
2014
Q3
$414K Sell
3,506
-1,102
-24% -$130K ﹤0.01% 1835
2014
Q2
$598K Buy
+4,608
New +$598K ﹤0.01% 1706